Literature DB >> 19755927

Acquisition of serum antibodies reactive with enterohemorrhagic Escherichia coli virulence-associated factors by healthy Brazilian children and adults.

Patricia Palmeira1, Solange B Carbonare, Beatriz E C Guth, Cristiane B Carbonare, Gerlândia N Pontes, Milene Tino-De-Franco, Lucy B Zapata-Quintanilla, Magda Carneiro-Sampaio.   

Abstract

BACKGROUND: Patients with hemorrhagic colitis or hemolytic uremic syndrome due to enterohemorrhagic Escherichia coli (EHEC) develop serum IgM and IgG response to lipopolysaccharide (LPS) and to virulence factors such as intimin. The small numbers of cases of diarrhea associated with EHEC strains in Brazil suggests a pre-existing immunity probably due to previous contact with diarrheagenic E. coli. Our aim was to evaluate the development of the serum antibody repertoire to EHEC virulence factors in Brazilian children and adults.
METHODS: Serum IgM and IgG antibodies were determined by enzyme-linked immunosorbent assay with LPS O111, LPS O26, and LPS O157 in 101 children between 2 months and 10 years of age and in 100 adult sera, by immunoblotting with protein membrane extracts and purified beta intimin; the ability of adult sera to neutralize Shiga toxin2 was also investigated.
RESULTS: Children older than 24 months had IgM concentrations reactive with the 3 LPS equivalent to those seen in the adult group, and significantly higher than the group of younger children (P < 0.05). Anti-O26 and anti-O157 LPS IgG concentrations were equivalent between the 2 groups of children and were significantly different from the adult group (P < 0.05). The anti-O111 LPS IgG levels in older children were intermediate between the younger group, and adults (P < 0.05). Immunoblotting revealed strong protein reactivity, including the conserved and variable regions of beta intimin and more than 50% of the adult samples neutralized Shiga toxin 2.
CONCLUSIONS: Our results demonstrate an increasing anti-LPS and antiprotein antibody response with age, which could provide protection against EHEC infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755927     DOI: 10.1097/INF.0b013e3181aa6b2d

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.

Authors:  Maurílio F Santos; Roger R C New; Gabrielle R Andrade; Christiane Y Ozaki; Osvaldo A Sant'Anna; Lucia Mendonça-Previato; Luis R Trabulsi; Marta O Domingos
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

2.  EHEC O111:H8 strain and norovirus GII.4 Sydney [P16] causing an outbreak in a daycare center, Brazil, 2019.

Authors:  Liliana Cruz Spano; Caroline Gastaldi Guerrieri; Luís Fernando Dos Santos; Tulio Machado Fumian; Lays Paula Bondi Volpini; Ricardo Pinto Schuenck; Jaqueline Pegoretti Goulart; Elizabeth Boina; Celia Regina Nascimento Recco; Rodrigo Ribeiro-Rodrigues
Journal:  BMC Microbiol       Date:  2021-03-29       Impact factor: 3.605

3.  Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls.

Authors:  Mirian Guirro; Roxane Maria Fontes Piazza; Renato Lopes de Souza; Beatriz Ernestina Cabilio Guth
Journal:  BMC Infect Dis       Date:  2014-06-11       Impact factor: 3.090

4.  Comment on "Shiga-Toxin Producing Escherichia coli in Brazil: A Systematic Review. Microorganisms 2019, 7, 137".

Authors:  Beatriz E C Guth
Journal:  Microorganisms       Date:  2019-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.